This result suggested a possible way to repress EGFR inhibitor resistance, that is, the effectiveness of EGFR inhibitors in lung cancer might be improved by methylation modification of genes that are closely related to EGFR inhibitors resistance. Here, EGFR is linked to lung carcinoma.